1997;127:337 45. S9.3-13. Reboussin DM, Allen NB, Griswold ME, et al. Systematic review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ ASPC/NMA/PCNA guideline for the prevention, detection, evalu- ation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:e116 e135. S9.3-14. Muntner P, Anderson A, Charleston J, et al. Hypertension aware- ness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2010;55:441 51. S9.3-15. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guide- line for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507 20. S9.3-16. National Clinical Guideline Centre (UK). Chronic Kidney Disease (Partial Update): Early Identification and Management of Chronic Kidney Disease in Adults in Primary and Secondary Care. London, UK: National Institute for Health and Care Excellence (UK); 2014. S9.3-17. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guide- lines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34:2159 219. S9.3-18. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int Suppl (2011). 2012;2(5):337 414. S9.3-19. Kanno A, Metoki H, Kikuya M, et al. Usefulness of assessing masked and white-coat hypertension by ambulatory blood pressure Whelton et al 2017 High Blood Pressure Clinical Practice Guideline e97 monitoring for determining prevalent risk of chronic kidney dis- ease: the Ohasama study. Hypertens Res. 2010;33:1192 8. S9.3-20. Terawaki H, Metoki H, Nakayama M, et al. 